Search Results - "Burchert, Andreas"

Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations.

Authors: Eckardt, Jan-Niklas Stölzel, Friedrich Kunadt, Desiree et al.

Source: Journal of Hematology & Oncology. 5/13/2022, Vol. 15 Issue 1, p1-13. 13p.

Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of TP53 mutations – a registry based analysis.

Authors: Middeke, Jan M. Teipel, Raphael Röllig, Christoph et al.

Source: Leukemia & Lymphoma. Jun2021, Vol. 62 Issue 6, p1432-1440. 9p.

Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma — a critical review and evaluation of the existing evidence.

Authors: Reinecke, Maximilian J. Ahlers, Gerrit Burchert, Andreas et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. 2022, Vol. 49 Issue 9, p3247-3256. 10p. 2 Charts, 2 Graphs.

Presentation of extramedullary myeloma manifestations on B-mode (B-US) and contrast-enhanced ultrasound (CEUS).

Authors: Trenker, Corinna Görg, Christian Burchert, Andreas et al.

Source: Journal of Ultrasonography. Apr2025, Vol. 25 Issue 101, p1-6. 6p. 2 Color Photographs, 1 Chart, 3 Graphs.

Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis‐associated adhesion of ovarian cancer cells.

Authors: Neuhaus, Felix Lieber, Sonja Shinkevich, Veronika et al.

Source: Clinical & Translational Medicine. Apr2024, Vol. 14 Issue 4, p1-24. 24p.

Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantation.

Authors: Christen, Deborah Sohlbach, Kristina Metzelder, Stephan K. et al.

Source: Leukemia & Lymphoma. Aug2019, Vol. 60 Issue 8, p2056-2061. 6p.

Interferon α and T-cell responses in chronic myeloid leukemia.

Authors: Burchert, Andreas Neubauer, Andreas

Source: Leukemia & Lymphoma. Feb2005, Vol. 46 Issue 2, p167-175. 9p.

Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia.

Authors: Eckardt, Jan-Niklas Stasik, Sebastian Kramer, Michael et al.

Source: Cancers. May2021, Vol. 13 Issue 9, p2095-2095. 1p.

Determinants for transformation induced by the Axl receptor tyrosine kinase.

Authors: Burchert, Andreas Attar, Eyal C McCloskey, Patrick et al.

Source: Oncogene. 6/18/98, Vol. 16 Issue 24, p3177. 11p.

Poor-risk cytogenetics may be associated with inferior outcome after fludarabine, cytarabine, and amsacrine reduced intensity conditioning in patients with high-risk acute myeloid leukemia.

Authors: Wilhelm, Christian Neubauer, Andreas Burchert, Andreas

Source: Leukemia & Lymphoma. Oct2011, Vol. 52 Issue 10, p2031-2035. 5p. 1 Chart, 1 Graph.

Sorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutation.

Authors: Fouladi, Fariba Jehn, Lutz B. Metzelder, Stephan K. et al.

Source: Leukemia & Lymphoma. Sep2015, Vol. 56 Issue 9, p2690-2698. 9p.

Nuclear factor of activated T-cells, NFATC1, governs FLT3^ITD-driven hematopoietic stem cell transformation and a poor prognosis in AML.

Authors: Solovey, Maria Wang, Ying Michel, Christian et al.

Source: Journal of Hematology & Oncology. 7/8/2019, Vol. 12 Issue 1, pN.PAG-N.PAG. 1p.

IRF8 Is an AML-Specific Susceptibility Factor That Regulates Signaling Pathways and Proliferation of AML Cells.

Authors: Liss, Franziska Frech, Miriam Wang, Ying et al.

Source: Cancers. 2/15/2021, Vol. 13 Issue 4, p764-764. 1p.

Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems.

Authors: Jentzen, Walter Weise, Reiner Kupferschläger, Jürgen et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Mar2008, Vol. 35 Issue 3, p611-623. 13p. 1 Diagram, 3 Charts, 6 Graphs.

Klonale Hämatopoese – Ursachen und klinische Implikationen.

Transliterated Title: Clonal hematopoiesis: causes and clinical implications.

Authors: Burchert, Andreas

Source: Der Internist Oct2022; Vol. 63 (10).

Journal Info: Publisher: Springer Nature ISSN: 0020-9554

Energy Efficiency in Strategy of Sustainable Production IV

Authors: Jörg Franke Michael Scholz Annika Höft

Resource Type: eBook.

Subjects: Production engineering--Technological innovations--Congresses, Manufacturing processes--Technological innovations--Congresses

Categories: TECHNOLOGY & ENGINEERING / Materials Science / General, TECHNOLOGY & ENGINEERING / Engineering (General), TECHNOLOGY & ENGINEERING / Mechanical

Transliterated Title: Abstracts zum 130. Kongress der Deutschen Gesellschaft für Innere Medizin e.V.

Source: Innere Medizin (Heidelberg, Germany) [Inn Med (Heidelb)] 2024 Apr; Vol. 65 (Suppl 1), pp. 1-181.

Publication Type: Journal Article

Journal Info: Publisher: Springer Medizin Country of Publication: Germany NLM ID: 9918384885306676 Publication Model: Print Cited Medium: Internet ISSN: 2731-7099 (Electronic) Linking ISSN: 27317080 NLM ISO Abbreviation: Inn Med (Heidelb) Subsets: MEDLINE; PubMed not MEDLINE

Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.

Authors: Isfort S Manz K Teichmann LL et al.

Corporate Authors: Isfort S Manz K Teichmann LL et al.

Source: Annals of hematology [Ann Hematol] 2023 Oct; Vol. 102 (10), pp. 2741-2752. Date of Electronic Publication: 2023 Aug 18.

Publication Type: Clinical Trial, Phase II; Multicenter Study; Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome.

Authors: Georgi JA Stasik S Eckardt JN et al.

Corporate Authors: Georgi JA Stasik S Eckardt JN et al.

Source: Blood cancer journal [Blood Cancer J] 2023 May 26; Vol. 13 (1), pp. 88. Date of Electronic Publication: 2023 May 26.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome.

Authors: Eckardt JN Stasik S Röllig C et al.

Source: Blood cancer journal [Blood Cancer J] 2023 Jan 24; Vol. 13 (1), pp. 18. Date of Electronic Publication: 2023 Jan 24.

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE